Reply: Chemotherapy for Invasive Papillary Carcinoma: Survival Benefit or Patient Selection?

Yi-Zi Zheng1,2, Zhuo-Zhao Zhan3, Ting-Ting Wu1

  • 1Department of Breast Surgery, Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.

The Oncologist
|August 4, 2026
PubMed
Abstract

No abstract available in PubMed .